A study of a medicine for heavy bleeding after childbirth in India
Part of Women’s health & pregnancy clinical trials.
This study tests a medicine called eptacog alfa to see if it is safe for women in India who have severe bleeding after giving birth. It is for women who did not get better with standard treatments to help the uterus contract.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult woman aged 18 years or older.
- You gave birth after 27 weeks of pregnancy.
- You are diagnosed with severe bleeding after childbirth that did not stop with standard medicines.
- You do not have a history of blood clots or bleeding disorders.
- You do not have certain severe pregnancy complications like HELLP syndrome or pre-eclampsia.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new under-the-tongue tablet (sublingual oxytocin) to prevent heavy bleeding after childbirth. It aims to see if it works safely in healthy women having a vaginal delivery at full term.
This trial tests two emergency treatments to control heavy bleeding after childbirth when standard medicines haven't worked. One uses a small balloon placed inside the womb, and the other uses a special gauze that helps blood clot.
This trial studies whether tranexamic acid can prevent heavy bleeding after a planned or urgent cesarean delivery in people with placenta previa. If you qualify, you may receive the study drug to help your body keep blood loss lower during and after surgery.
This trial tests whether tranexamic acid (a medicine that helps blood clot) can prevent heavy bleeding after delivery in women who are at higher risk. If it works, it may lower the chance of serious postpartum bleeding and related complications.
This trial studies whether tranexamic acid, a medicine that helps blood clot, can prevent postpartum hemorrhage (heavy bleeding after delivery) in people having a planned C-section or likely vaginal delivery after 34 weeks. It may help lower the risk of dangerous bleeding around the time of birth.
This study looks for hidden bleeding problems in women who had severe bleeding after giving birth vaginally. If you had heavy bleeding during delivery, this trial could help find out if you have a condition that caused it.
Hear when a new Severe Postpartum Haemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.